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Introduction
Cluster headache (CH) is an uncommon primary head-
ache that may be difficult to diagnose when comorbid
with other headache disorders [1]. We describe two
patients with a challenging diagnosis, emerging after
treatment with botulinum toxin (BTX).
Case 1
A 58-year-old man presented with a three decades his-
tory of almost daily unilateral, not side-locked, pulsating
head pain with severe exacerbations, lasting 4-72 hours,
associated with photo-, phono-, and osmophobia, con-
junctival injection, increasing with physical activity.
Indomethacin overuse was present and the patient met
diagnostic criteria for both chronic migraine (CM) and
medication-overuse headache. He had tried, over the
years, several drugs (antiepileptics, such as, valproate
and topiramate, antidepressants, calcium-channel block-
ers, and beta blockers) and non-pharmacological treat-
ments (biofeedback, acupuncture) with only transient
improvements. Treatment with BTX, according to the
PREEMPT injection protocol [2], was started together
with venlafaxine and steroids for two weeks with mild
improvement of the headache. After two cycles of treat-
ment with BTX, the patient developed attacks of stab-
bing pain localized behind his right eye, spreading to
the right side of the head, with marked conjunctival
injection. The pain recurred 8-10 times per day, usually
lasting about 60 minutes, and was associated with rest-
lessness. CH was diagnosed. Steroids and verapamil, as
well as subcutaneous sumatriptan in acute attacks, were
started with cessation of the CH attacks and persistence
of migraine attacks. Four months later, CH attacks
relapsed and were again successfully treated.
Case 2
A 41-year-old woman presented with a history of pul-
sating pain in the left, sometimes right, temporal
region and behind the eye associated with ipsilateral
lacrimation, photo-, phonofobia and vomiting occur-
ring 15 times a month, lasting 12-24 hours and fulfill-
ing diagnostic criteria for CM. Drug prophylaxis with
amitriptyline and flunarizine was initiated but stopped
for ineffectiveness and side effects. Treatment with
BTX, according to the PREEMPT [2] injection protocol
was started with complete cessation of attacks. After
three cycles of treatment, the patient developed stab-
bing pain localized behind her left eye with autonomic
signs, spreading to the left side of the head, recurring
3-4 times per day and lasting 60-120 minutes, fulfilling
diagnostic criteria for CH. BTX was stopped; treatment
with steroids and topiramate was initiated with resolu-
tion of the attacks. Off the cluster, the patient autono-
mously withdrew all treatments with recurrence of
migraine-type headache; BTX was restarted with good
response.
Discussion
In our opinion, in both the cases there was a comorbid-
ity between chronic migraine and CH. In the former
case the presence of CH was covered up by the promi-
nence of migraine features and by the effects of preven-
tive and acute phase treatments used to treat migraine
that may also have limited the disclosure of CH symp-
toms thus making its diagnosis more challenging. In the
second case, CH developed during treatment with BTX
and, although unlikely, we do not know if and how BTX
could have trigger CH.
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